Products
Deferiprone
Deferiprone is an orally active iron chelator specifically designed to bind iron in a 3:1 (deferiprone:iron) molar ratio. It is primarily used to treat iron overload (hemosiderosis) in patients with thalassemia major who have inadequate response to other chelation therapies. It facilitates the mobilization and subsequent excretion of toxic excess tissue iron through the urine.
Get Top-Quality Deferiprone Pharmaceutical Ingredient in India
Product Specifications
| Deferiprone API Technical Details | |
|---|---|
| Product Name | Deferiprone |
| Category | Active Pharmaceutical Ingredient (API) |
| Chemical Name | 3‑Hydroxy‑1,2‑dimethylpyridin‑4‑one |
| CAS Number | 30652‑11‑0 |
| Molecular Formula | C₇H₉NO₂ |
| Molecular Weight | 139.15 g/mol |
| Pharmacopoeia Compliance | IP / BP / USP (as per requirement) |
| Therapeutic/Application | Iron chelator for transfusional iron overload |
| Form | Crystalline Powder |
| Packaging | HDPE container / HDPE drum with inner liner |
| Shelf Life | 24 months from date of manufacture |
| Storage Conditions | Store below 30 °C, protect from light and moisture |
| Certifications / Compliance | In‑house QC tested; GMP compliant facility |
Deferiprone is a high‑value oral iron chelator used globally to manage transfusional iron overload in patients with thalassaemia, sickle cell disease, and other transfusion‑dependent anemias. As a critical API, it enables formulation of life‑saving chelation therapies that improve long‑term outcomes for chronically transfused patients.
As a premier API manufacturer in India, SNA Healthcare is focused on providing you reliable, high‑quality Deferiprone API. We work as one of the leading Deferiprone API suppliers in India who understands that clients depend on this active ingredient for their finished formulations. So, we deliver a consistent, well‑characterized product which can be a trusted foundation for your pharmaceutical manufacturing.
Deferiprone Role in Iron Chelation Therapy
Oral Iron Chelation for Transfusional Overload
Deferiprone is a bidentate chelating agent that preferentially binds ferric iron (Fe³⁺) in a 3:1 (deferiprone:iron) complex, facilitating iron excretion primarily via urine. This makes it a core API for oral chelation regimens in thalassaemia and related conditions.
Flexible Formulation Options
The API is suitable for development of immediate‑release tablets, film‑coated tablets, and oral solution formulations, enabling multiple dosage forms to meet diverse patient and market needs.
Strong Clinical Adoption
Deferiprone is approved and widely used in major markets (including US, EU, and India) under brands such as Ferriprox, supporting robust demand for high‑quality API from GMP‑compliant manufacturers.
Quality‑Driven Synthesis
In multi‑step synthesis of chelation therapies, the quality of the API directly impacts safety and efficacy. Our Deferiprone is manufactured under controlled conditions with in‑house QC testing to ensure consistent purity and performance.
Fulfill Your Needs for Deferiprone API!
You can see the value of a critical API like Deferiprone in the final medicinal product. As a foundational Deferiprone pharmaceutical ingredient India trusts, its quality is the first and most important step in any chelation therapy formulation. SNA Healthcare provides a product that you can rely on for your most critical manufacturing processes. Contact us if you need to buy Deferiprone API in India.
